How many clinical trials are studying RMC-9805?

4 recruiting trials in our tracked data involve RMC-9805.

What conditions is RMC-9805 being studied for?

In our tracked recruiting trials, RMC-9805 is being studied in trials for Lung Cancer, Pancreatic cancer, Colorectal Cancer.

Recruiting trials

Conditions studied

US states with sites

Countries

Phase 1 4 Phase 2 3

Condition	Trials
Lung Cancer · RMC-9805 for Lung Cancer	3
Pancreatic cancer · RMC-9805 for Pancreatic cancer	3
Colorectal Cancer	2
Non-Small Cell Lung Cancer, NSCLC	2
PDAC	2
Advanced Solid Tumors	1
CRC	1
Colorectal Cancer (CRC)	1
Gastrointestinal Cancer	1
KRAS G12C-mutated Solid Tumors, Lung Cancer	1
KRAS, NRAS, HRAS-mutated NSCLC	1
Lung Cancer Stage IV, Advanced Solid Tumor, Cancer	1
MTAP Deletion	1
Metastatic Pancreatic Ductal Adenocarcinoma	1
NSCLC	1

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
NCT06162221 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 93 locations
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
NCT06445062 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 64 locations
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
NCT06040541 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 17 locations
Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
NCT06922591 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 18 locations